Search
for
Sort by
Research 691–720 of 1000+
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Cutaneous lupus erythematosus
- Acquired scalp alopecia. Part I: A review
- Skin manifestations of hyperandrogenism: an update
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
- Current treatment of BPH
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- INCIDENCE OF VIRILISATION IN SEX CORD STROMAL TUMOURS OF OVARY, A 5- YEAR EXPERIENCE IN A TERTIARY CARE GYNAECOLOGICAL CENTRE
- Novel prospectives of shikimic acid and Prunus mume extract for enhancing bioactivity on 5α-reductase and stability in cosmetic patches for acne treatment
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Evaluation and treatment of male and female pattern hair loss
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- Anti-hair Loss Potential of Acanthus ebracteatus (Sea Holly) in Cell Culture Assays and an Open-label, Non-comparative Clinical Trial
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Genetic Defects of Female Sexual Differentiation
- Organizational Effects of Estrogens and Androgens on Estrogen and Androgen Receptor Expression in Pituitary and Adrenal Glands in Adult Male and Female Rats
- Immune therapies for alopecia areata: evidence and new perspectives
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- Alopecia Areata: An Updated Review for 2023